Navigation Links
Dragon retains leading investor relations firm
Date:3/17/2008

VANCOUVER, March 17 /PRNewswire-FirstCall/ - Dragon Pharmaceutical Inc. ("Dragon" or the "Company" TSX: DDD; OTCBB: DRUG; BBSE: DRP), a leading international pharmaceutical company, today announced it has retained cQuest, a capital markets advisory affiliate of Christensen, to facilitate and execute its investor and media relations campaigns. cQuest specializes in assisting companies with market capitalizations of less than $200 million to achieve fair market valuation and strengthen brand recognition in the global financial markets and financial media. Retaining cQuest reinforces Dragon's commitment to maximizing shareholder value by improving external communications and increasing visibility within the financial community.

"We are very excited to be working with cQuest," said Ms. Maggie Deng, Dragon's Chief Operating Officer. "The Dragon management team is committed to creating value for our shareholders with best-in-class communications and has placed a great deal of effort in finding the right investor relations firm to accomplish this goal. With its extensive global investor relations expertise with small and micro-cap companies and depth of pharmaceutical industry experience, we are confident that cQuest will assist in positioning Dragon Pharmaceutical within the investor community with a more comprehensive and customized investor and media relations program, a critical step to achieving our long term goals."

About Dragon Pharmaceutical Inc.

--------------------------------

Dragon Pharmaceutical, headquartered in Vancouver, Canada, is a leading manufacturer and distributor of a broad line of high-quality antibiotic products including 7-ACA, a key intermediate to produce cephalosporin antibiotics, Clavulanic Acid, and formulated cephalosporin antibiotic drugs. Dragon is the third largest 7-ACA producer and the first manufacturer and market leader of Clavulanic Acid products in China. Dragon utilizes its nationwide sales distri
'/>"/>

SOURCE Dragon Pharmaceutical Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Dragon Pharmaceutical Reports Growth in Sales and Profits during Second Quarter of 2007
2. Strong Demand Pushes up Both Prices and Sales Volumes for Dragons Main Products
3. Dragon Announces R&D Achievement in Biotech Manufacturing Process
4. Dragon announces new product launch; increase in annual production output capacity
5. Biomoda, Inc. Retains MicroCap Management, LLC as its Lead Corporate Communications and Broker Relations Firm.
6. China Pharma Holdings, Inc. Retains HC International, Inc. to Implement Investor Relations Program
7. Carrington Retains Milkie/Ferguson to Explore Financial Alternatives
8. NuRx Pharmaceuticals Retains Russo Partners for Investor Relations, Corporate Communications Counsel
9. BioMarin Licenses Technology From Leading Cystic Fibrosis Research Laboratory at the University of California, San Francisco
10. Elekta Contract Provides Sisters of Mercy Health System Access to Leading Radiation Therapy Solutions
11. United BioSource Acquires Interest in Leading Adaptive Design Technology Service Provider
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/19/2013)... Md. , June 19, 2013 Synthetic Biologics, ... the prevention and treatment of serious infectious diseases, announced today ... 6 th Annual OneMedForum New York Conference on Thursday, ... New York City . Mr. Riley is scheduled to ... webcast of Synthetic Biologics, presentation can be accessed by logging ...
(Date:6/19/2013)... Bayer CropScience will honor Illinois beekeeper ... Community Leadership Award. The award will be announced at ... Washington, D.C., an event where supporters of pollinator health ... supply. , The Bayer Bee Care Community Leadership ... the honey bee colony to benefit their community. Applicants ...
(Date:6/19/2013)... (PRWEB) June 19, 2013 BioConvergence ... the speaking faculty at 2013’s BioLogistics Summit in ... conference, coordinated by Cold Chain IQ and IQPC, ... This “complexity” is, in part, attributed to current ... , “Implicit within these trends is an increase ...
(Date:6/19/2013)... MN (PRWEB) June 19, 2013 Express ... abuse tests, today announced that it has received Class ... market and sell its DrugCheck® NxStep Onsite Drug ... use of the rapid screening device in near-patient settings, ... Drug Screen Cup received Health Canada Class III approval ...
Breaking Biology Technology:Synthetic Biologics to Present at OneMedForum New York 2013 2Community Mentor Wins Inaugural Bayer CropScience Bee Care Leadership Award 2Community Mentor Wins Inaugural Bayer CropScience Bee Care Leadership Award 3Community Mentor Wins Inaugural Bayer CropScience Bee Care Leadership Award 4BioConvergence® Presents at BioLogistics Summit on Risk Matrix for Biosamples during Shipment 2Express Diagnostics’ DrugCheck® On-site Test Cup Receives Health Canada Class III Medical Device Approval 2Express Diagnostics’ DrugCheck® On-site Test Cup Receives Health Canada Class III Medical Device Approval 3
... the U.S. Department of Energy,s Argonne National Laboratory, will ... 138 on Nanoalloys: From Theory to Application, to be ... in the United Kingdom. , The Faraday Discussions are ... have been of enormous influence in reviewing the current ...
... Stevens Institute of Technology and NACE International, ... Section, will host the Winter 2007 Corrosion Symposium: ... Charles V. Schaefer, Jr. School of Engineering & ... Keith Sheppard, a professor materials engineering, will welcome ...
... splinting and bracing technology, ST. PAUL, ... of St. Paul, Minn., and Product Innovations, ... announce the launch of Exos Corporation, a ... innovative orthopedic,support devices. Exos will focus ...
Cached Biology Technology:Enova Medical Launches Exos Corporation 2
(Date:6/19/2013)... specifically for human consumption qualifies as a gluten-free cereal ... (CD), scientists have confirmed in a study published in ... , Joyce Irene Boye and colleagues point out ... States alone have CD. They develop gastrointestinal and other ... that contain gluten-related proteins. Boye,s team sought to expand ...
(Date:6/19/2013)... ITHACA, N.Y. A Cornell University study offers further ... 4 million to 6 million years ago was profoundly ... in turning genes on and off. , The study, ... evidence for a 40-year-old hypothesis that regulation of genes ... is little difference between humans and chimps in the ...
(Date:6/19/2013)... world-leading provider of scientific, technical and medical information products ... a new open access journal, GeoResJ . ... earth and planetary science journals portfolio has its first ... a forum for rapid publication of top research within ... co-edited by six Executive Editors, each covering a different ...
Breaking Biology News(10 mins):New research backs theory that genetic 'switches' play big role in human evolution 2New research backs theory that genetic 'switches' play big role in human evolution 3
... by the journal Nature until January 30, 1 PM Eastern ... Research Institute have identified a pathway in the brain that ... The findings suggest a new target for anti-smoking therapies. ... issue of the journal Nature . In the ...
... University of California, San Diego School of Medicine ... cognitive defects associated with a rare childhood neurological ... to be defective in LND are known to ... Alzheimer,s and Parknson,s diseases, suggesting common causes of ...
... statistically significant level to their sons, and the same is ... it does not seem to impact on the probability of ... not affect his daughter", Loureiro, a researcher at the Universidade ... the study, tells SINC. The research, which has been ...
Cached Biology News:Scripps Research scientists reveal key mechanism governing nicotine addiction 2Scripps Research scientists reveal key mechanism governing nicotine addiction 3Genetic clues to compulsive, self-injurious behavior in rare childhood disorder 2Genetic clues to compulsive, self-injurious behavior in rare childhood disorder 3Smoking habits are transmitted from mother to daughter and father to son 2
... Triple-angle light scattering detector for ... digital signal processing hardware for two ... UV detectors. Also contains an analog ... interfacing to strip chart recorders. Includes ...
...
MAb to Verotoxin II (SLT-2a) Verotoxin II (Shiga-like) A subunit (SLT-2a)...
... BIP-NC H-IPMIK-OH ... PROTECT FROM LIGHT. HYGROSCOPIC. PACKAGED UNDER INERT ... Bax-Inhibiting Peptide, V5 (Cat. No. 196810) that ... suppress Bax-mediated apoptosis (~200 μM). Purity: ...
Biology Products: